sIPV+DTaP+HepA
sIPV-DTaP-HepA-2020
Approved mab active
Quick answer
sIPV+DTaP+HepA for Vaccination is a Approved program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Vaccination
- Phase
- Approved
- Modality
- mab
- Status
- active